Wednesday, July 8, 2026

pharma · Advanced Solid Tumors · Solid Tumor · PYXS

Pyxis Oncology

Pyxis Oncology clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Boston, USA HQ
2019 Founded
71 Employees
Public company Type
PYXS · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2019
Employees
71
Programs
8
Drugs
6
Patents
3
Intelligence · Clinical Programs

Pyxis Oncology projects

3 ClinicalTrials.gov programs sponsored by Pyxis Oncology.

Pyxis Oncology has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. APX005M

    Pyxis Oncology

    Melanoma

    phase 2 small molecule terminated

    1 trial
  2. PYX-201

    Pyxis Oncology

    Advanced Solid Tumors

    phase 2 small molecule active

    1 trial
  3. PYX-201-102

    Pyxis Oncology

    Advanced Solid Tumors

    phase 2 other active

    1 trial

Frequently asked questions

How many clinical projects does Pyxis Oncology have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.